Resistance to Photodynamic Therapy in Cancer Resistance to Photodynamic Therapy in Cancer
Book 5 - Resistance to Targeted Anti-Cancer Therapeutics

Resistance to Photodynamic Therapy in Cancer

    • €87.99
    • €87.99

Publisher Description

This volume provides a comprehensive review of resistance induced by photodynamic therapy (PDT) in tumor cells. Understanding the underlying mechanisms in this process leads to the improvement of therapeutic modality, in combination with chemotherapy, immunotherapy, and radiotherapy. Photodynamic therapy is a minimally invasive therapeutic procedure that can exert a selective or preferential cytotoxic activity toward malignant cells. The procedure involves administration of an intrinsically non-toxic photosensitizing agent (PS) followed by irradiation at a wavelength corresponding to a visible absorption band of the sensitizer. In the presence of oxygen, a series of events lead to direct tumor cell death, damage to the microvasculature, and induction of a local inflammatory reaction. Studies reveal that PDT can be curative, particularly in early stage tumors and this volume explores the potential of PDT, but also reveals strategic approaches to overcome resistance in tumor cells.

GENRE
Professional & Technical
RELEASED
2014
11 December
LANGUAGE
EN
English
LENGTH
263
Pages
PUBLISHER
Springer International Publishing
SIZE
3.7
MB

Other Books in This Series

Resistance to Immunotoxins in Cancer Therapy Resistance to Immunotoxins in Cancer Therapy
2015
Resistance of Cancer Cells to CTL-Mediated Immunotherapy Resistance of Cancer Cells to CTL-Mediated Immunotherapy
2015
Resistance to Aromatase Inhibitors in Breast Cancer Resistance to Aromatase Inhibitors in Breast Cancer
2015
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy
2016
Resistance to Tyrosine Kinase Inhibitors Resistance to Tyrosine Kinase Inhibitors
2016
Resistance to Targeted Therapies Against Adult Brain Cancers Resistance to Targeted Therapies Against Adult Brain Cancers
2016